Advertisement Pharmaceutical Business review - Page 1196 of 5279 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
June 25, 2026

RQ Bio secures $115m to develop influenza antibody programme

UK-based RQ Bio has closed a £85.5m ($115m) Series A funding round to advance its long-acting antibody therapeutic programme RQB01, which targets influenza prevention in high-risk and immunocompromised groups.

Continue
RQ Bio CEO Mike Westby. Credit: RQ Bio/GlobeNewswire.
June 25, 2026

MSD’s Keytruda-Padcev combo secures EC approval for MIBC

The authorisation applies to adults with resectable MIBC who cannot be treated with cisplatin-based chemotherapy. Credit: Antonio Marca / Shutterstock.com.
June 24, 2026

Boehringer and Combotope partner for cancer antibodies

The agreement initially covers multiple oncology targets named by Boehringer Ingelheim. Credit: Tada Images / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Haisco and Nuvectis sign licensing deal for two drugs
  2. Genprex’s Reqorsa combo secures Canadian patent for lung cancer
  3. Lilly and BioArctic sign deal to develop neurodegenerative therapy
  4. Sun Pharma to acquire Innovcare Lifesciences for $28.7m
  5. Japan approves Sanofi’s Sarclisa combo for MM treatment

PRESS RELEASES

Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C
Protecting Precious Therapies: SCHOTT Pharma Unveils Polymer Syringe for Ultra-Low Temperature Storage at -180°C
Pharmaceutical Business Review
Redefining Safety, Efficiency, and Sustainability: SCHOTT Pharma Launches Next-Generation Polymer Syringe System
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography